ZFAS1 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: ZFAS1 is a potential novel therapeutic target for PACA metabolic therapy and mechanistically improves the relationship between the primary regulator of EMT, ZEB1, and the important kinase AMPK [81].